Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria

Detalhes bibliográficos
Autor(a) principal: Franklin, Bernardo Simões
Data de Publicação: 2011
Outros Autores: Ishizaka, Sally T., Lamphier, Marc, Gusovsky, Fabian, Hansen, Hans, Rose, Jeffrey, Zheng, Wanjun, Ataíde, Marco Antônio, Oliveira, Rosane Barbosa de, Golenbock, Douglas Taylor, Gazzinelli, Ricardo Tostes
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/8684
Resumo: Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Imunopatologia. Belo Horizonte, MG, Brazil/University of Massachusetts. Medical School. Department of Medicine. Division of Infectious Diseases and Immunology. Worcester, MA
id CRUZ_f9233b95dd1d4905192d1ce5152a0918
oai_identifier_str oai:www.arca.fiocruz.br:icict/8684
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Franklin, Bernardo SimõesIshizaka, Sally T.Lamphier, MarcGusovsky, FabianHansen, HansRose, JeffreyZheng, WanjunAtaíde, Marco AntônioOliveira, Rosane Barbosa deGolenbock, Douglas TaylorGazzinelli, Ricardo Tostes2014-10-28T17:13:42Z2014-10-28T17:13:42Z2011FRANKLIN, Bernardo Simões et al. Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria. P NATL ACAD SCI USA, 108(9): 3689-3694, 2011.0027-8424https://www.arca.fiocruz.br/handle/icict/8684engAcademy of Sciences of the United States of AmericaTherapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malariainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Imunopatologia. Belo Horizonte, MG, Brazil/University of Massachusetts. Medical School. Department of Medicine. Division of Infectious Diseases and Immunology. Worcester, MAEisai Research Institute. Andover, MAEisai Research Institute. Andover, MAEisai Research Institute. Andover, MAEisai Research Institute. Andover, MAEisai Research Institute. Andover, MAEisai Research Institute. Andover, MAFundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Imunopatologia. Belo Horizonte, MG, Brazil/Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Imunopatologia. Belo Horizonte, MG, BrazilFundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Imunopatologia. Belo Horizonte, MG, BrazilFundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Imunopatologia. Belo Horizonte, MG, Brazil/Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Imunopatologia. Belo Horizonte, MG, BrazilFundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Imunopatologia. Belo Horizonte, MG, Brazil/Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Departamento de Bioquimica e Imunologia. Belo Horizonte, MG, BrazilExcessive release of proinflammatory cytokines by innate immune cells is an important component of the pathogenic basis of malaria. Proinflammatory cytokines are a direct output of Toll-like receptor (TLR) activation during microbial infection. Thus, interference with TLR function is likely to render a better clinical outcome by preventing their aberrant activation and the excessive release of inflammatory mediators. Herein, we describe the protective effect and mechanism of action of E6446, a synthetic antagonist of nucleic acid-sensing TLRs, on experimental cerebral malaria (ECM) induced by Plasmodium berghei ANKA. We show that in vitro, low doses of E6446 specifically inhibited the activation of human and mouse TLR9. Tenfold higher concentrations of this compound also inhibited the human TLR8 response to single-stranded RNA. In vivo, therapy with E6446 diminished the activation of TLR9 and prevented the exacerbated cytokine response observed during acute Plasmodium infection. Furthermore, severe signs of ECM, such as limb paralysis, brain vascular leak, and death, were all prevented by oral treatment with E6446. Hence, we provide evidence that supports the involvement of nucleic acid-sensing TLRs in malaria pathogenesis and that interference with the activation of these receptors is a promising strategy to prevent deleterious inflammatory responses that mediate pathogenesis and severity of malaria.Immunotherapyinnate immunitynucleic acid recognitioninflammationinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-81914https://www.arca.fiocruz.br/bitstream/icict/8684/1/license.txt7d48279ffeed55da8dfe2f8e81f3b81fMD51ORIGINALTherapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria.pdfTherapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria.pdfapplication/pdf1304082https://www.arca.fiocruz.br/bitstream/icict/8684/2/Therapeutical%20targeting%20of%20nucleic%20acid-sensing%20Toll-like%20receptors%20prevents%20experimental%20cerebral%20malaria.pdf32809b05c1e6bbae808d147ce8bcc16bMD52TEXTTherapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria.pdf.txtTherapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria.pdf.txtExtracted texttext/plain41363https://www.arca.fiocruz.br/bitstream/icict/8684/3/Therapeutical%20targeting%20of%20nucleic%20acid-sensing%20Toll-like%20receptors%20prevents%20experimental%20cerebral%20malaria.pdf.txtb85f59207135f0b68ca3389da92e3ad9MD53icict/86842019-06-19 10:12:16.521oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352019-06-19T13:12:16Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria
title Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria
spellingShingle Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria
Franklin, Bernardo Simões
Immunotherapy
innate immunity
nucleic acid recognition
inflammation
title_short Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria
title_full Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria
title_fullStr Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria
title_full_unstemmed Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria
title_sort Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria
author Franklin, Bernardo Simões
author_facet Franklin, Bernardo Simões
Ishizaka, Sally T.
Lamphier, Marc
Gusovsky, Fabian
Hansen, Hans
Rose, Jeffrey
Zheng, Wanjun
Ataíde, Marco Antônio
Oliveira, Rosane Barbosa de
Golenbock, Douglas Taylor
Gazzinelli, Ricardo Tostes
author_role author
author2 Ishizaka, Sally T.
Lamphier, Marc
Gusovsky, Fabian
Hansen, Hans
Rose, Jeffrey
Zheng, Wanjun
Ataíde, Marco Antônio
Oliveira, Rosane Barbosa de
Golenbock, Douglas Taylor
Gazzinelli, Ricardo Tostes
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Franklin, Bernardo Simões
Ishizaka, Sally T.
Lamphier, Marc
Gusovsky, Fabian
Hansen, Hans
Rose, Jeffrey
Zheng, Wanjun
Ataíde, Marco Antônio
Oliveira, Rosane Barbosa de
Golenbock, Douglas Taylor
Gazzinelli, Ricardo Tostes
dc.subject.en.pt_BR.fl_str_mv Immunotherapy
innate immunity
nucleic acid recognition
inflammation
topic Immunotherapy
innate immunity
nucleic acid recognition
inflammation
description Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Imunopatologia. Belo Horizonte, MG, Brazil/University of Massachusetts. Medical School. Department of Medicine. Division of Infectious Diseases and Immunology. Worcester, MA
publishDate 2011
dc.date.issued.fl_str_mv 2011
dc.date.accessioned.fl_str_mv 2014-10-28T17:13:42Z
dc.date.available.fl_str_mv 2014-10-28T17:13:42Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv FRANKLIN, Bernardo Simões et al. Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria. P NATL ACAD SCI USA, 108(9): 3689-3694, 2011.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/8684
dc.identifier.issn.none.fl_str_mv 0027-8424
identifier_str_mv FRANKLIN, Bernardo Simões et al. Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria. P NATL ACAD SCI USA, 108(9): 3689-3694, 2011.
0027-8424
url https://www.arca.fiocruz.br/handle/icict/8684
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Academy of Sciences of the United States of America
publisher.none.fl_str_mv Academy of Sciences of the United States of America
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/8684/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/8684/2/Therapeutical%20targeting%20of%20nucleic%20acid-sensing%20Toll-like%20receptors%20prevents%20experimental%20cerebral%20malaria.pdf
https://www.arca.fiocruz.br/bitstream/icict/8684/3/Therapeutical%20targeting%20of%20nucleic%20acid-sensing%20Toll-like%20receptors%20prevents%20experimental%20cerebral%20malaria.pdf.txt
bitstream.checksum.fl_str_mv 7d48279ffeed55da8dfe2f8e81f3b81f
32809b05c1e6bbae808d147ce8bcc16b
b85f59207135f0b68ca3389da92e3ad9
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009069508657152